Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Resource Type
Article
Authors
Weber, Jeffrey S ; D'Angelo, Sandra P ; Minor, David ; Hodi, F Stephen ; Gutzmer, Ralf ; Neyns, Bart ; Hoeller, Christoph ; Khushalani, Nikhil I ; Miller, Wilson H, Jr ; Lao, Christopher D ; Linette, Gerald P ; Thomas, Luc ; Lorigan, Paul ; Grossmann, Kenneth F ; Hassel, Jessica C ; Maio, Michele ; Sznol, Mario ; Ascierto, Paolo A ; Mohr, Peter ; Chmielowski, Bartosz ; Bryce, Alan ; Svane, Inge M ; Grob, Jean-Jacques ; Krackhardt, Angela M ; Horak, Christine ; Lambert, Alexandre ; Yang, Arvin S ; Larkin, James
Source
In The Lancet Oncology April 2015 16(4):375-384
Subject
Primary Research Articles
Language
ISSN
1470-2045